Leaky Gut, Gum Disease, and Chronic Illness: What’s the Link?

Leaky gut, periodontal disease, and chronic illness might sound dry, but they are deeply connected and highly relevant to your health. Framing these topics in a clearer, more urgent way may help you take action.

If I told you your gut can influence periodontal disease, you might be curious. But if I said an unhealthy gut—commonly called leaky gut—can undermine your health and even increase your risk of dying from chronic disease, that should get your attention.

In the United States, about 70% of deaths are caused by chronic conditions. Periodontal disease often appears early in the course of chronic disease development, so addressing both gum disease and gut health could meaningfully reduce long-term risk.

Gut Function 101

The digestive tract begins in the mouth and extends to the anus. This continuous tube—also known as the gastrointestinal or alimentary canal—is lined with similar tissues throughout, so what affects one section can influence others. What happens in the intestines can affect the mouth, and vice versa.

The intestinal lining is a single layer of epithelial cells that forms a selective barrier between the gut lumen and the rest of the body. This barrier allows nutrients to pass into the bloodstream while keeping harmful substances out.

Over that epithelial surface sits a mucus layer that protects the lining and works with the immune system. The mucus reduces inflammation by limiting contact between living microbes in the lumen and the epithelial cells.

Your microbiome—the collection of microbes living on the mucous surface and in the lumen—outnumbers your human cells. There are roughly 30 trillion human cells, but around 38 trillion microbial cells in and on your body, many of them in the gut. These microbes are essential for metabolism, nutrition, immune function, and general physiology.

When the gut microbiome becomes imbalanced and unhealthy microbes overgrow, a wide array of chronic conditions can follow.

What happens when the gut and oral microbiota are out of balance?

When harmful bacteria and other insults damage the epithelial barrier, substances from the gut can leak into the bloodstream. This condition is commonly called leaky gut, or increased intestinal permeability.

Toxic elements entering the circulation can drive chronic inflammation and promote chronic disease. Periodontal disease is one of the chronic conditions that can emerge in the context of gut dysfunction.

Equally important, once periodontal disease is present it creates another portal for harmful agents to enter the body—a “leaky periodontal pocket.” In other words, both a leaky gut and leaky periodontal tissues are potential sources of systemic inflammation and disease.

Both conditions can and should be addressed to prevent or reduce chronic disease risk.

Here are some of the systemic diseases associated with intestinal permeability or dysbiosis of the oral or gut microbiome:

  1. Inflammatory bowel disease (Crohn’s disease and ulcerative colitis)
  2. Irritable bowel syndrome
  3. Esophageal and colorectal cancers
  4. Allergies
  5. Respiratory and other infections
  6. Chronic and acute inflammation
  7. Metabolic diseases (diabetes, heart disease, and related conditions)
  8. Alzheimer’s disease
  9. Autoimmune diseases such as rheumatoid arthritis and celiac disease

Current Research on Leaky Gut, Periodontitis, & Chronic Disease

Each year research uncovers more about how the gut, its microbial community, and the mouth interact and contribute to chronic disease. Connecting these findings helps clinicians design more effective treatment strategies that target the root contributors to disease.

Several notable findings include:

  • Damage to the gut can impair immune function and promote chronic disease.
  • Leaky gut has been implicated as a contributing factor in conditions such as multiple sclerosis and other chronic illnesses.
  • Inflammatory bowel disease can influence the expression of inflammatory markers in gum tissue and contribute to periodontal disease.
  • Periodontal disease has been linked to a higher risk of atherosclerosis and cardiovascular complications.
  • A double-blind trial found that a spore-based probiotic taken for 30 days improved markers of intestinal permeability even without dietary changes.
  • Research shows mitochondrial dysfunction in gingival cells contributes to periodontal disease.
  • Studies suggest vitamin K2 can support mitochondrial function and may help prevent or repair mitochondrial damage.

These findings point to a multi-system pathway: gut dysbiosis can lead to leaky gut, which impairs immune function and may trigger mitochondrial damage across tissues, increasing vulnerability to chronic disease, including periodontitis.

Future Areas of Research

Putting these pieces together suggests new therapeutic opportunities. If gut imbalances and intestinal permeability contribute to systemic inflammation and mitochondrial dysfunction, then interventions that restore gut health and support cellular energy systems could reduce disease risk.

Promising approaches include spore-based probiotics to rebalance the gut microbiome and vitamin K2 to support mitochondrial health. Based on this hypothesis, a clinical trial was developed to test whether improving gut health could help heal periodontal disease.

The trial submitted to an Institutional Review Board in 2018 is double-blinded and randomized. It involves roughly 20 participants with active periodontal disease who receive either a placebo or a supplement containing five spore-based probiotics and vitamin K2 for six weeks. Investigators measure pocket depths, bleeding, mitochondrial health, and changes in the oral microbiome at baseline and after the intervention.

The expectation is that participants taking the supplement will show reduced pocket depths and bleeding, improved mitochondrial function, and a healthier oral microbiome. If the results are positive, further studies could expand and confirm these findings, potentially altering how periodontal and other chronic diseases are treated.

How to support a healthy digestive system and oral health

Many habits that support gut health also benefit oral health. Practical measures with strong evidence include:

  1. Maintain consistent oral hygiene: manage biofilm through regular brushing and flossing, and remove trapped food particles.
  2. Avoid routine use of strong antiseptic mouthwashes, which can kill beneficial oral bacteria and contribute to dry mouth, decay, and gum problems.
  3. Monitor gum health with your dentist or periodontist to catch gingivitis or advancing periodontitis early.
  4. Support gut health with spore-based probiotics, a diet rich in fermented and probiotic foods, and reduced intake of processed foods and simple carbohydrates.

Further updates will follow once the clinical study is complete and results are available.

Dr. Al Danenberg is a recognized nutritional periodontist who continues to consult with patients. He provides online consultations by appointment.

References
  1. Raghupathi, W., & Raghupathi, V. (2018). An empirical study of chronic diseases in the United States: a visual analytics approach to public health. International Journal of Environmental Research and Public Health, 15(3), 431.
  2. Pickard, J. M., Zeng, M. Y., Caruso, R., & Núñez, G. (2017). Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunological Reviews, 279(1), 70-89.
  3. Bischoff, S. C., et al. (2014). Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterology, 14(1), 189.
  4. Dominy, S. S., et al. (2019). Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Science Advances, 5(1), eaau3333.
  5. Pabst, O., da Cunha, A. P., & Weiner, H. L. (2015). Mechanisms of oral tolerance to soluble protein antigens. In Mucosal Immunology (pp. 831-848). Academic Press.
  6. Buscarinu, M. C., et al. (2018). Intestinal permeability in relapsing-remitting multiple sclerosis. Neurotherapeutics, 15(1), 68-74.
  7. Figueredo, C. M., et al. (2017). Activity of inflammatory bowel disease influences the expression of cytokines in gingival tissue. Cytokine, 95, 1-6.
  8. Bale, B. F., Doneen, A. L., & Vigerust, D. J. (2017). High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis. Postgraduate Medical Journal, 93(1098), 215-220.
  9. McFarlin, B. K., et al. (2017). Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers. World Journal of Gastrointestinal Pathophysiology, 8(3), 117.
  10. Li, X., Wang, X., Zheng, M., & Luan, Q. X. (2016). Mitochondrial reactive oxygen species mediate the lipopolysaccharide-induced pro-inflammatory response in human gingival fibroblasts. Experimental Cell Research, 347(1), 212-221.
  11. Vos, M., et al. (2012). Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science, 336(6086), 1306-1310.
  12. Ivanova, D., et al. (2018). Vitamin K: redox-modulation, prevention of mitochondrial dysfunction and anticancer effect. Redox Biology, 16, 352-358.